Search results
Obesity drug rivals aim to unseat Zepbound, Ozempic - Indianapolis Business Journal
Indianapolis Business Journal· 3 days agoInsatiable demand for weight-loss drugs has made the market so feverish that any positive mention of...
Amgen: Q1 Earnings Snapshot
San Mateo Daily Journal· 3 days agoTHOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Amgen Inc. (AMGN) on Thursday reported a first-quarter loss of $113 million, after reporting a profit in the same period
Novo Slides as Amgen Fuels Obesity Drug Competition Fears
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Novo Nordisk A/S shares fell as a US rival’s comments on an experimental obesity drug...
Wall Street Inches Up After Powell's Inflation Remarks; Chipmakers Rebound; Gold, Crude Falter:...
Benzinga via Yahoo Finance· 3 days agoU.S. stock markets surged during Thursday’s midday trading session in New York, with major averages...
Amgen investors await weight-loss drug data
Reuters· 5 days ago, opens new tab investors eyeing dramatic share price gains for rivals with successful obesity drugs will be focused on any updates the biotech company...
Nasdaq, S&P 500 Futures Signal Higher Open On Apple's Boost: Will Non-Farm Payrolls Data Play...
Benzinga· 3 days agoStocks look set to carry forward the upward momentum on Friday amid some earnings cheer, although a...
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Zacks· 6 days agoThe Earnings Trends report indicates that as of Apr 24, 16.7% of the companies in the Medical sector — representing 32.6% of the sector’s market capitalization — reported quarterly earnings.
European Stocks Gain on Earnings as US Data Fuels Rate-Cut Bets
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- European stocks gained on Friday, boosted by strong earnings and as traders pulled...
Novo Slides as Amgen Fuels Obesity Drug Competition Fears
Bloomberg· 3 days agoHave a confidential tip for our reporters? Novo Nordisk A/S shares fell as a US rival’s comments on...
Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value...
Benzinga· 2 days agoAmgen earnings beat estimates, and MariTide's promising Phase 2 results suggest significant...
